Syphilis diagnostic rate - WMCA

All infectious syphilis (primary, secondary and early latent) diagnoses among people accessing sexual health services* in England who are also residents in England, expressed as a rate per 100,000 population. Data is presented by area of patient residence and includes those residents in England and those with an unknown residence (data for those residents outside of England is not included).*Sexual health services providing STI related care (Levels 2 and 3). Further details on the levels of sexual healthcare provision are provided in the  https://www.bashh.org/about-bashh/publications/standards-for-the-management-of-stis/ .RationaleSyphilis is an important public health issue in men who have sex with men (MSM) among whom incidence has increased over the past decade.Definition of numeratorThe number of infectious syphilis (primary, secondary and early latent) diagnoses among people accessing sexual health services in England who are also residents in England.Episode Activity codes (SNOMED or Sexual Health and HIV Activity Property Types (SHHAPT)) relating to diagnosis of infectious syphilis (primary, secondary and early latent) were used. The clinical criteria used to diagnose the conditions are given at  https://www.bashh.org/guidelines .Data was de-duplicated to ensure that a patient received a diagnostic code only once for each episode. Patients cannot be tracked between clinics and therefore de-duplication relies on patient consultations at a single service.Definition of denominatorThe denominators for 2012 to 2022 are sourced from Office for National Statistics (ONS) population estimates based on the 2021 Census.Population estimates for 2023 were not available at the time of publication – therefore rates for 2023 are calculated using estimates from 2022 as a proxy.Further details on the ONS census are available from the https://www.ons.gov.uk/census .CaveatsEvery effort is made to ensure accuracy and completeness of GUMCAD data, including web-based reporting with integrated checks on data quality. However, responsibility for the accuracy and completeness of data lies with the reporting service.Data is updated on an annual basis due to clinic or laboratory resubmissions and improvements to data cleaning. Data may differ from previous publications.Figures reported in 2020 and 2021 are notably lower than previous years due to the disruption to SHSs during the national response to the COVID-19 pandemic.

英格兰境内接受性健康服务的人群中所有感染梅毒（包括初期、二期和早期潜伏期）的诊断病例，以每10万人中的发生率表示。数据按患者居住区域分类展示，包括英格兰居民以及居住地不明的个体（不包括英格兰以外居民的病例）。性健康服务提供与性传播感染相关的护理（二级和三级）。有关性健康护理提供级别的详细信息请参考https://www.bashh.org/about-bashh/publications/standards-for-the-management-of-stis/。梅毒是男性同性恋者（MSM）中的一个重要公共卫生问题，过去十年中其发病率有所上升。
定义分子：英格兰境内接受性健康服务且居住在英格兰的人群中感染梅毒（包括初期、二期和早期潜伏期）的诊断病例数。用于诊断感染梅毒的相关代码（SNOMED或性健康和HIV活动属性类型（SHHAPT））被采用。用于诊断这些疾病的临床标准可在https://www.bashh.org/guidelines上找到。数据经过去重处理，以确保每位患者在每个病例中仅获得一次诊断代码。由于患者无法在诊所之间追踪，因此去重依赖于单一服务中的患者咨询。
定义分母：2012年至2022年的分母数据来源于基于2021年人口普查的英国国家统计局（ONS）人口估计。2023年的人口估计数据在发布时不可用，因此2023年的发生率使用2022年的估计值作为代理。有关ONS人口普查的更多详细信息，请访问https://www.ons.gov.uk/census。
注意事项：尽管我们尽力确保GUMCAD数据的准确性和完整性，包括基于网络的报告以及数据质量的集成检查，但数据准确性和完整性的责任仍由报告服务承担。数据每年更新一次，由于诊所或实验室的重新提交和数据清洗的改进。数据可能与以前的出版物不同。2020年和2021年报告的数字明显低于前几年，这是由于应对COVID-19大流行期间性健康服务（SHS）的干扰造成的。